Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Roger R. Dmochowski; Kenneth M. Peters; Jon D. Morrow; Zhonghong Guan; Jason Gong; Franklin Sun; Paul Siami; David R. Staskin

doi:10.1016/j.urology.2009.09.018

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Urology ◽

10.1016/j.urology.2009.09.018 ◽

2010 ◽

Vol 75 (1) ◽

pp. 62-68 ◽

Cited By ~ 63

Author(s):

Roger R. Dmochowski ◽

Kenneth M. Peters ◽

Jon D. Morrow ◽

Zhonghong Guan ◽

Jason Gong ◽

...

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Flexible Dose

Download Full-text

Re: Randomized, Double-Blind, Placebo-Controlled Trial of Flexible-Dose Fesoterodine in Subjects With Overactive Bladder

The Journal of Urology ◽

10.1016/s0022-5347(11)60409-6 ◽

2011 ◽

Vol 186 (3) ◽

pp. 993-994

Author(s):

Steven A. Kaplan

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Flexible Dose

Download Full-text

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793478312 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women

Phytomedicine ◽

10.1016/j.phymed.2012.10.007 ◽

2013 ◽

Vol 20 (3-4) ◽

pp. 351-358 ◽

Cited By ~ 11

Author(s):

Cornelia Betschart ◽

Ursula von Mandach ◽

Burkhardt Seifert ◽

David Scheiner ◽

Daniele Perucchini ◽

...

Keyword(s):

Overactive Bladder ◽

Postmenopausal Women ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Bryophyllum Pinnatum

Download Full-text

190 SOLIFENACIN SIGNIFICANTLY IMPROVES OVERACTIVE BLADDER (OAB) SYMPTOMS, SYMPTOM-ASSOCIATED BOTHER AND OTHER PATIENT-REPORTED OUTCOMES: RESULTS FROM VIBRANT, A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(09)60195-0 ◽

2009 ◽

Vol 8 (4) ◽

pp. 168 ◽

Cited By ~ 1

Author(s):

T.A. Samuels ◽

H.D. Mitcheson ◽

M.D. Vardy ◽

S. Forero-Schwanhaeuser ◽

T. Marshall ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Patient Reported

Download Full-text

Re: Chen H. et al: Efficacy of Daily Low-dose Tadalafil for Treating Overactive Bladder: Results of a Randomized, Double-blind, Placebo-controlled Trial (Urology 2016;100:59-64)

Urology ◽

10.1016/j.urology.2016.12.023 ◽

2017 ◽

Vol 101 ◽

pp. 177

Author(s):

Yubo Yang ◽

Yunjin Bai ◽

Xiaoming Wang ◽

Ping Han

Keyword(s):

Overactive Bladder ◽

Low Dose ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Editorial Comment from Dr Dmochowski to Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial

International Journal of Urology ◽

10.1111/j.1442-2042.2011.02740.x ◽

2011 ◽

Vol 18 (5) ◽

pp. 374-374

Author(s):

Roger R Dmochowski

Keyword(s):

Overactive Bladder ◽

Editorial Comment ◽

Controlled Trial ◽

Japanese Patients ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793482693 ◽

2013 ◽

Author(s):

Hashim Hashim ◽

Riyad Almousa

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF THE ONCE DAILY ANTIMUSCARINIC AGENT SOLIFENACIN SUCCINATE IN PATIENTS WITH OVERACTIVE BLADDER

The Journal of Urology ◽

10.1097/01.ju.0000140729.07840.16 ◽

2004 ◽

Vol 172 (5) ◽

pp. 1919-1924 ◽

Cited By ~ 237

Author(s):

L. CARDOZO ◽

M. LISEC ◽

R. MILLARD ◽

O. van VIERSSEN TRIP ◽

I. KUZMIN ◽

...

Keyword(s):

Overactive Bladder ◽

Controlled Trial ◽

Antimuscarinic Agent ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Solifenacin Succinate

Download Full-text

Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2009.02209.x ◽

2009 ◽

Vol 63 (12) ◽

pp. 1702-1714 ◽

Cited By ~ 38

Author(s):

M. D. Vardy ◽

H. D. Mitcheson ◽

T.-A. Samuels ◽

J. D. Wegenke ◽

S. Forero-Schwanhaeuser ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Symptom Bother ◽

Patient Reported ◽

Bladder Symptoms

Download Full-text

Re: Chen et al.: Efficacy of Daily Low-dose Tadalafil for Treating Overactive Bladder: Results of a Randomized, Double-blind, Placebo-controlled Trial (Urology 2017;100:59-64)

Urology ◽

10.1016/j.urology.2016.12.001 ◽

2017 ◽

Vol 102 ◽

pp. 267

Author(s):

Dechao Feng ◽

Yin Tang

Keyword(s):

Overactive Bladder ◽

Low Dose ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text